Biomarker for Detection of Mental Disorders in Women, Novel Gene-Control Molecule Targets Chronic Wounds, Gene Therapy for Treatment of Parkinson’s Disease - Genetic Technology

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a biomarker for detection of mental disorders in women, a novel gene-control molecule that targets chronic wounds, and gene therapy for treatment of Parkinson’s disease.

Table of Contents

Genetic Technology Alert. Biomarker for Detection of Mental Disorders in Women; Novel Gene-Control Molecule Targets Chronic Wounds; Gene Therapy for Treatment of Parkinson’s DiseaseIn This Issue1. BIOMARKER FOR DETECTION OF MENTAL DISORDERS IN WOMEN2. NOVEL GENE-CONTROL MOLECULE TARGETS CHRONIC WOUNDS3. GENE THERAPY FOR TREATMENT OF PARKINSON’S DISEASE4. GLOBAL PATENTS ON THE DIAGNOSIS AND TREATMENT OF THALASSEMIA5. TECHVISION 2015




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.